C. Serradeil‐Le Gal

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

C. Serradeil‐Le Gal, Jean Wagnon, Corinne Garcia et al. · Journal of Clinical Investigation · 1993 · 272 citations · Full text

Avp V2, Immunology, Pharmacotherapy +18

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

C. Serradeil‐Le Gal, C Lacour, G Valette et al. · Journal of Clinical Investigation · 1996 · 247 citations · Full text

Molecular Pharmacology, Selective Affinity, Arginine Vasopressin +14

Endothelin action in rat liver. Receptors, free Ca2+ oscillations, and activation of glycogenolysis.

C. Serradeil‐Le Gal, Catherine Jouneaux, A Sanchez-Bueno et al. · Journal of Clinical Investigation · 1991 · 110 citations · Full text

Cellular Pharmacology, Experimental Pharmacology, Cellular Physiology +21

Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors.

Ariane Mallat, Anne-Marie Préaux, C. Serradeil‐Le Gal et al. · Journal of Clinical Investigation · 1996 · 103 citations · Full text

Hepatic Stellate Cells, Immunology, Cell Death +21

Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells

C. Serradeil‐Le Gal, Jean‐Marc Herbert, Chantal Delisée et al. · American Journal of Physiology-Heart and Circulatory Physiology · 1995 · 53 citations

Hypertension, Immunology, Cardiovascular Function +17